BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9557822)

  • 1. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH, IGFBP-1, and IGFBP-3 response to oral glucose tolerance test in perimenopausal women: no influence of body mass index.
    Bernardi F; Petraglia F; Seppälä M; Spinetti A; Bertolini S; Driul L; Ferdeghini M; Genazzani AR
    Maturitas; 1999 Oct; 33(2):163-9. PubMed ID: 10597881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A; Castelo-Branco C; Tarín JJ
    Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD
    J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
    De Marinis L; Mancini A; Valle D; Bianchi A; De Luca AM; Fulghesu AM; Villa P; Mancuso S; Lanzone A
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
    Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.
    Bondanelli M; Ambrosio MR; Margutti A; Boldrini P; Basaglia N; Franceschetti P; Zatelli MC; Degli Uberti EC
    Metabolism; 2002 Oct; 51(10):1363-9. PubMed ID: 12370860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in total ghrelin within the somatotropic axis in severe burn patients: comparison of those with inhalation injury and those without inhalation injury.
    Lee BW; Park SH; Ihm SH; Kim JH; Kim DH; You KC; Kim SW; Yoo HJ
    Growth Horm IGF Res; 2008 Aug; 18(4):291-7. PubMed ID: 18178497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.
    Juul A; Scheike T; Pedersen AT; Main KM; Andersson AM; Pedersen LM; Skakkebaek NE
    Hum Reprod; 1997 Oct; 12(10):2123-8. PubMed ID: 9402266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
    Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
    Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone in obesity.
    Scacchi M; Pincelli AI; Cavagnini F
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects.
    Street ME; Smerieri A; Montanini L; Predieri B; Iughetti L; Valenzise M; De Luca F; Vigone M; Weber G; Maghnie M; Bernasconi S
    J Biol Regul Homeost Agents; 2013; 27(1):259-66. PubMed ID: 23489706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women.
    Di Somma C; Rivellese A; Pizza G; Patti L; De Rosa A; Cipriano P; Nedi V; Rossi A; Lombardi G; Colao A; Savastano S
    J Endocrinol Invest; 2011 Feb; 34(2):90-6. PubMed ID: 21502796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.